YSB's (HKG:9885) profit attributable to owners surged to 153 million yuan for 2025 from 30 million yuan a year earlier, according to a Monday Hong Kong bourse filing.
Earnings per share at the pharmaceutical retailer came in at 0.220 yuan, compared with 0.046 yuan a year earlier.
Revenue rose 17% to 21 billion yuan from 17.9 billion yuan.
The board recommended a final dividend of 0.110 yuan per share, equivalent to HK$0.125 per share, subject to shareholder approval at the annual general meeting on May 21.
The dividend will be paid in Hong Kong dollars on or around June 24 to shareholders on record as of June 2.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments